324
Views
39
CrossRef citations to date
0
Altmetric
Original Articles

Antihypertensive Activities of a Solid-State Culture of Taiwanofungus camphoratus (Chang-Chih) in Spontaneously Hypertensive Rats

, , , , , & show all
Pages 23-30 | Received 15 May 2006, Accepted 12 Sep 2006, Published online: 22 May 2014

  • 1) Mark, K. S., and Davis, T. P., Stroke: development, prevention and treatment with peptidase inhibitors. Peptides, 21, 1965–1973 (2000).
  • 2) Dunbabin, D., Cost-effective intervention in stroke. Pharmacoeconomics, 2, 468–499 (1992).
  • 3) Fotherby, M. D., and Panayiotou, B., Antihypertensive therapy in the prevention of stroke: what, when, and for whom? Drugs, 58, 663–674 (1999).
  • 4) Mullally, M. M., Meisel, H., and FitzGerald, R. J., Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem., 377, 259–260 (1996).
  • 5) Ariyoshi, Y., Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci. Technol., 4, 139–144 (1993).
  • 6) Pihlanto-Leppälä, A., Rokka, T., and Korhonen, H., Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int. Dairy J., 8, 325–331 (1998).
  • 7) Pihlanto-Leppälä, A., Koskinen, P., Piilola, K., Tupasela, T., and Korhonen, H., Angiotensin I-converting enzyme inhibitory properties of whey protein digest: concentration and characterization of active peptides. J. Dairy Res., 67, 53–64 (2000).
  • 8) Pihlanto-Leppälä, A., Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci. Technol., 11, 347–356 (2001).
  • 9) Maruyama, S., Mitachi, H., Awaya, J., Kurono, M., Tomizuka, N., and Suzuki, H., Angiotensin I-converting enzyme inhibitory activity of the C-terminal hexapeptide of as1-casein. Agric. Biol. Chem., 51, 2557–2561 (1987).
  • 10) Kohmura, M., Nio, N., Kubo, K., Minoshima, Y., Munekata, E., and Ariyoshi, Y., Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein. Agric. Biol. Chem., 53, 2107–2114 (1989).
  • 11) Maeno, M., Yamamoto, N., and Takano, T., Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci., 79, 1316–1321 (1996).
  • 12) Miyoshi, S., Ishikawa, H., Kaneko, T., Fukui, F., Tanaka, H., and Maruyama, S., Structures and activity of angiotensin-converting enzyme inhibitors in an α-zein hydrolysate. Agric. Biol. Chem., 55, 1313–1318 (1991).
  • 13) Yano, S., Suzuki, K., and Funatsu, G., Isolation from α-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity. Biosci. Biotechnol. Biochem., 60, 661–663 (1996).
  • 14) Chen, T. L., Ken, K. S., and Chang, H. M., Study on the preparation of angiotensin-converting enzyme inhibitors (ACEI) from hydrolysates of gelatin. J. Chin. Agric. Chem. Soc., 37, 546–553 (1999).
  • 15) Hsu, F. L., Lin, Y. H., Lee, M. H., Lin, C. L., and Hou, W. C., Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1), and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities. J. Agric. Food Chem., 50, 6109–6113 (2002).
  • 16) Hou, W. C., Chen, H. J., and Lin, Y. H., Antioxidant peptides with angiotensin converting enzyme inhibitory activities and applications for angiotensin converting enzyme purification. J. Agric. Food Chem., 51, 1706–1709 (2003).
  • 17) Aviram, M., and Dornfeld, L., Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis, 158, 195–198 (2001).
  • 18) Actis-Goretta, L., Ottaviani, J. I., Keen, C. L., and Fraga, C. G., Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett., 555, 597–600 (2003).
  • 19) Liu, J. C., Hsu, F. L., Tsai, J. C., Chan, P., Liu, J. Y. H., Thomas, G. N., Tomlinson, B., Lo, M. Y., and Lin, J. Y., Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiotensin converting enzyme. Life Sci., 73, 1543–1555 (2003).
  • 20) Wu, S. H., Yu, Z. H., Dai, Y. C., Chen, C. T., Su, C. H., Chen, L. C., Hsu, W. C., and Hwang, G. Y., Taiwanofungus, a polypore new genus. Fung. Sci., 19, 109–116 (2004).
  • 21) Wu, S. H., Ryvarden, L., and Chang, T. T., Antrodia camphorata (“niu-chang-chih”), new combination of a medicinal fungus in Taiwan. Bot. Bull. Acad. Sin., 38, 273–275 (1997).
  • 22) Hsiao, G., Shen, M. Y., Lin, K. H., Lan, M. H., Wu, L. Y., Chou, D. S., Lin, C. H., Su, C. H., and Sheu, J. R., Antioxidative and hepatoprotective effects of Antrodia camphorata extract. J. Agric. Food Chem., 51, 3302–3308 (2003).
  • 23) Song, T. Y., and Yen, G. C., Protective effects of fermented filtrate from Antrodia camphorata in submerged culture against CCl4-induced hepatic toxicity in rats. J. Agric. Food Chem., 51, 1571–1577 (2003).
  • 24) Lee, I. H., Huang, R. L., Chen, C. T., Chen, H. C., Hsu, W. C., and Lu, M. K., Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiol. Lett., 209, 63–67 (2002).
  • 25) Nakamura, N., Hirakawa, A., Gao, J. J., Kakuda, H., Shiro, M., Komatsu, Y., Sheu, C. C., and Hattori, M., Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line. J. Nat. Prod., 67, 46–48 (2004).
  • 26) Song, T. Y., Hsu, S. L., Yeh, C. T., and Yen, G. C., Mycelia from Antrodia camphorata in submerged culture induce apoptosis of human hepatoma HepG2 cells possibly through regulation of Fas pathway. J. Agric. Food Chem., 53, 5559–5564 (2005).
  • 27) Chen, C. J., Su, C. H., and Lan, M. H., Study on solid cultivation and bioactivity of Antrodia camphorata. Fung. Sci., 16, 65–72 (2001).
  • 28) Holmquist, B., Bunning, P., and Riordan, J. F., A continuous spectrophotometric assay for angiotensin converting enzyme. Anal. Biochem., 95, 540–548 (1979).
  • 29) Chen, T. L., Lo, Y. C., Hu, W. T., Wu, M. C., Chen, S. T., and Chang, H. M., Microencapsulation and modification of synthetic peptides of food proteins reduces the blood pressure of spontaneously hypertensive rats. J. Agric. Food Chem., 51, 1671–1675 (2003).
  • 30) National Science Council, Guide for the care and use of laboratory animals, National Science Council, Taipei, Taiwan, Republic of China (1994).
  • 31) Hseu, Y. C., Chang, W. C., Hseu, Y. T., Lee, C. Y., Yech, Y. J., Chen, P. C., Chen, J. Y., and Yang, H. L., Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes. Life Sci., 71, 469–482 (2002).
  • 32) Cherng, I. H., and Chiang, H. C., Three new triterpenoids from Antrodia cinnamomea. J. Nat. Prod., 58, 365–371 (1995).
  • 33) Cherng, I. H., Wu, D. P., and Chiang, H. C., Triterpenoids from Antrodia cinnamomea. Phytochem., 41, 263–267 (1996).
  • 34) Shen, C. C., Kuo, Y. C., Huang, R. L., Lin, L. C., Dong, M. J., Chang, T. T., and Chou, C. J., New ergostane and lanostane from Antrodia camphorata. J. Chin. Med., 14, 247–258 (2003).
  • 35) Morigiwa, A., Kitabatake, K., Fujimoto, Y., and Ikekawa, N., Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem. Pharm. Bull., 34, 3025–3028 (1986).
  • 36) Rodriguez-Rodriguez, R., Perona, J. S., Herrera, M. D., and Ruiz-Gutierrez, V., Triterpenic compounds from “Orujo” olive oil elicit vasorelaxation in aorta from spontaneously hypertensive rats. J. Agric. Food Chem., 54, 2096–2102 (2006).
  • 37) Wang, G. J., Tseng, H. W., Chou, C. J., Tsai, T. H., Chen, C. T., and Lu, M. K., The vasorelaxation of Antrodia camphorata mycelia: involvement of endothelial Ca2+-NO-cGMP pathway. Life Sci., 73, 2769–2783 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.